(in alphabetical order)
Dr. Peter Fitzgerald is an Interventional Cardiologist and a Professor of Medicine at Stanford University, where he is the Director of the Center for Cardiovascular Technology and the Director of the Cardiovascular Core Analysis Laboratory. Dr. Fitzgerald has led and/or participated in over 100 clinical trials and has published over 350 articles and chapters in medical journals and text books.
In addition to his clinical expertise, Dr. Fitzgerald is able to gain granularity on a technology level, having a PhD in Biomedical Engineering. Furthermore, Dr. Fitzgerald brings extensive venture and start up experience to the fund, having been part of the founding team of more than a dozen medical device start ups, and having been one of the principle founders of Latterell Venture Partners, a large healthcare focused venture capital fund located in Silicon Valley. Dr.Fitzgerald serves on several boards, and is an advisor to many medical device start-ups and multinational healthcare companies.
Mr.Berman is a co-founder of Aetherworks, Apnex, BeneChill, and BridgePoint Medical. In addition he is an investor and board member of Data Sciences Int’l, Lutonix, PharmaCentra and UltraShape. In 2001 he co-founded Velocimed which was sold to St. Jude Medical in 2005. From 1995-2000 Mr. Berman was the President of the Cardiology business of Boston Scientific.Mr. Berman received his BS and MBA degrees from Cornell University in 1979 and 1986, respectively.
Mr. Doyle is a recognized expert in medical devices commercialization. As an executive at Johnson & Johnson, he was a member of J&J’s Medical Devices and Diagnostics Group Operating Committee with responsibility for licensing, acquisitions & strategy. During his tenure, J&J added several important franchises, including Cordis Corporation, DePuy Orthopedics and BioSense-Webster. Bill was also Chairman of J&J’s Medical Devices Research and Development Council, Worldwide President of Biosense-Webster, a director of Cordis Corporation and the medical device director of Johnson & Johnson Development Corporation (J&J's venture capital subsidiary).
Managing partner at Agate Venture, Founder & CEO Matar Capital Advisors. Former Director Business Development, Elron Electronic Industries, part of the IDB group (NASDAQ ELRN). Led Elron's Medical Device sector investments, served on the BOD of Elbit Vision Systems, Nulens, AMT, 3DV Systems & others. Former Head of investment banking Israel at ING Barings, the investment banking arm of ING Group. Vice President Investment Banking, Cukierman & Co., where he managed private placements and IPOs in Europe. Israel's Economic Consul in Boston, & Commercial Attache to South Korea. B.Sc. in Aeronautical Engineering from the Technion - Israel Institute of Technology. Member of the Technion Alumni 100 Club.
Mr. Nahir gained his professional expertise in several top management positions, including CEO of Chromogan, Tali Ltd. London, and his current position as Managing Director of the 260-employee company Degania Silicone. Internationally marketed and distributed, Degania Silicone is one of the three leading international manufacturers of silicone catheters. Mr. Nahir serves as the Chairman of the Board for several Degania Silicone subsidiaries in the USA and Germany. He holds a BA in Economics and Business from the University of Haifa, Israel.
Mr. Sebba is serving as Vice President of XT Investments. Prior to joining XT Investments, Yoav served as a partner at Yozma Venture Capital (which is part of the XT Investments portfolio), one of Israel’s leading venture capital firms. Prior to joining Yozma, Yoav served as a project manager at Bank Leumi, one of Israel’s leading commercial banks. Yoav is serving as a board member in ZIM Integrated Shipping Services, NanoPass, CorAssist, IntraTech, Angioslide and EndoCross. Yoav served as a board member in Cognitens (acquired by Hexagon), Kailight (acquired by Optium), Impactia (acquired by eWave), Applied Spectral Imaging, Tevet (acquired by NanoMetris), Yadata (acquired by Microsoft) & Next9. Yoav holds a B.Sc. in Industrial Engineering and Management, with distinction, from the Technion Institute of Technology, and an MBA from the Haifa University.
Chief Executive Officer
Mr. Avitov became Angioslide CEO in May 2011, following 4 years as the company's chairman. He most recently served as an EVP at Ofer Hi-Tech, one of Israel’s leading private equity firms, heading the healthcare team. Prior to that, he served as CEO of Naiot Venture Accelerator, and as General Manager of Rimlon, a medical device company in the orthopedics field.At Ofer Hi-Tech and Naiot Venture Accelerator, he led various investments in innovative healthcare technologies and played an active role in their day-to-day management. In 2007 Mr. Avitov co-founded PainReform, a startup dedicated to developing drug reformulations in the field of pain management. Mr. Avitov holds a bachelor's degree in Economics and Management, and a master's degree from the Department of Industrial Engineering and Management at the Technion – Israel Institute of Technology in Haifa, Israel.